Spectris /£SXS

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Spectris

Spectris plc is a UK-based company specializing in precision measurement solutions. Founded in 1915, it operates through high-tech instrument, test equipment, and software provision, catering to a range of technically demanding industries. The company is listed on the London Stock Exchange under the ticker symbol SXS and is organized into segments including Spectris Scientific and Spectris Dynamics.

Ticker

£SXS

Sector

Digital Hardware

Primary listing

LSE

Employees

7,400

Spectris Metrics

BasicAdvanced
£4B
70.76
£0.58
0.79
£0.83
2.04%

What the Analysts think about Spectris

Analyst ratings (Buy, Hold, Sell) for Spectris stock.

Bulls say / Bears say

Spectris posted an 8% rise in H1 2025 sales to £636.1 million and a 7% increase in adjusted operating profit to £65.6 million, driven by strong momentum in the second quarter.
The Profit Improvement Programme achieved savings of over £10 million in H1 2025 and projects more than £30 million for the full year, supporting margins and cash flow conversion.
Strategic acquisitions have boosted Spectris Scientific, which delivered 21% reported sales growth and a 70 bps improvement in operating margin in H1 2025, highlighting successful integration and synergy realization.
Like-for-like sales growth was just 1% in H1 2025, reflecting weakness in core markets such as semiconductors and automotive, signaling ongoing demand pressures.
Basic earnings per share dropped 20% to 38.4p in H1 2025, underscoring volatility in fundamental profitability measures.
Net debt jumped to £545.7 million in H1 2025 from a net cash position of £292.5 million a year earlier, raising leverage to 2.3× and heightening the group's financial risk.
Data summarised monthly by Lightyear AI. Last updated on 3 Sept 2025.

Spectris Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Spectris Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £SXS

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

Oct2
Spectris
DividendEx-dividend
Nov7
Spectris
DividendPayment
£0.28Per share
FAQs